3,4-Dichloro-2-fluorophenylboronic acid, 98%, 250mg

Methyl 1-phenyl-1H-imidazole-4-carboxylate, 95%, 100mg

1-(4-Aminophenyl)-1H-pyridin-2-one, 95.0%, 250mg

3-(Benzylamino)-4-nitrobenzoic acid, 96.0%, 1g

Cyclohexane-1,2,3-triol, 97%, 5g

Magnesium glycerophosphate hydrate, 11.0%, 25g

Anti-GD2 Monoclonal Antibody1vial

Methyl 4-Bromo-2-(bromomethyl)benzoate>97.0%(GC)200mg

2-Amino-2-(4-ethoxyphenyl)acetic acid, 95%, 250mg

3-(4-(Trifluoromethyl)phenyl)propan-1-amine, 95+%, 500mg

Methyl 2-Hydroxynicotinate, 97.0%, 100g

3-Chloro-5-(trifluoromethyl)pyrazine-2-carbonitrile, 97%, 100mg

4-Pyridinecarboxamide, N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]-, 98%, 1g